Skip to main content
. 2014 Jul 16;9(7):e102221. doi: 10.1371/journal.pone.0102221

Figure 1. Scheme of our search strategy.

Figure 1

(a) anti-leukemic drugs were selected using three approaches: kinase inhibitor library screens, correlation analysis, and literature survey. (b) Dose responses of single agent and pair-wise analysis with a fixed dose of imatinib (pairs and triplets) were performed. (c) The drug combinations were optimized using iterative search algorithm (d) The optimal drug combinations were validated with primary patient cells.